Alpha‐blockers vs placebo or control: Incidence of recurrent urinary retention
Alpha blocker probably leads to lower incidence of recurrent urinary retention compared with placebo or control (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Alpha blocker vs placebo or control Incidence of recurrent urinary retention · acute urinary retention in adult men Alpha blocker probably leads to lower incidence of recurrent urinary retention compared with placebo or control (moderate certainty). The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men (2014) · Cochrane Headline outcomes only | RR 0.69 [0.6, 0.79] | 8 studies · 1023 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men 2014 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.